iPRF for hair

When iPRF is injected into the scalp, growth factors are released gradually and support follicle activity and the growth environment.

The natural fibrin network allows sustained release of active components, providing ongoing support for scalp renewal.

The treatment may help by:

• Stimulating hair follicle activity
• Extending the active growth phase of the hair (Anagen)
• Improving blood supply to follicles
• Encouraging new blood vessel formation (angiogenesis)
• Reducing inflammatory processes around follicles
• Improving scalp quality

The goal is to create an optimal growth environment for hair follicles as part of a comprehensive plan tailored to the cause of hair loss.

The treatment may suit a range of hair loss and thinning conditions, including:

• Androgenetic alopecia in men
• Androgenetic alopecia in women
• Diffuse hair thinning
• Reduced hair density
• Fine, weak hair
• Postpartum hair loss
• Telogen effluvium (when appropriate)
• Adjunct care after hair transplantation
• Combination with Minoxidil, Finasteride, and dutasteride

Suitability is determined after medical assessment, according to the type of hair loss, scalp condition, and follicle status.

Treatment begins with a simple blood draw. After centrifuge processing, iPRF is produced and injected into thinning areas of the scalp with fine injections.

The procedure usually takes 30–60 minutes. In most cases a series of treatments is recommended, followed by maintenance sessions as needed.

iPRF and PRP are both based on the patient’s own blood, but they differ in how the product is prepared and in its composition. Thanks to the natural fibrin network, iPRF allows more gradual, sustained release of growth factors, and in many cases is an advanced option for treating hair loss.

The choice between treatments is made according to the patient’s condition and treatment goals.

No. Effectiveness depends on the cause of hair loss, follicle condition, and disease stage.

Before treatment begins, a comprehensive medical assessment is performed, including history, clinical examination, and sometimes laboratory tests, to tailor an individual treatment plan.

iPRF is an important tool in hair medicine, but in most cases it is part of a comprehensive plan. Depending on the cause of hair loss, the plan may also include medication, supplements, additional regenerative treatments, or addressing risk factors, to treat the underlying cause and achieve optimal long-term results.

Some patients notice reduced shedding within the first weeks. Improvements in density, hair thickness, and quality develop gradually over several months, according to the natural hair growth cycle.

Usually not. iPRF is a biological treatment that works gradually, so a series of 3–4 treatments at intervals of several weeks is often recommended, followed by maintenance as needed.

Yes. iPRF can be combined with Minoxidil, Finasteride, dutasteride, mesotherapy, laser treatments, exosomes, hair transplantation, and other options.

In many cases, combining several methods addresses multiple mechanisms of hair loss at once and improves outcomes. The combination is decided after medical assessment according to the cause of hair loss.

Because the treatment is based on the patient’s own blood, the risk of allergic reaction or rejection is very low.

After treatment, local, temporary effects may occur, such as:

• Redness at the injection area
• Scalp sensitivity
• Mild swelling
• Small bruises at injection points
• Mild discomfort the day after treatment

In most cases you can return to routine the same day. As with any medical treatment, rarer risks and side effects also exist. Before each treatment, a medical consultation is held to assess suitability and fully explain benefits, risks, and possible side effects as part of informed consent.